Clusters of Circulating let-7 Family Tumor Suppressors Are Associated with Clinical Characteristics of Chronic Hepatitis C

Hepatitis C virus (HCV) infections can cause permanent liver-related diseases, including hepatocellular carcinoma (HCC). Low mortality and incidence of HCC have been observed in patients with chronic hepatitis C undergoing direct-acting antiviral therapy. Tumor suppressive let-7 family members are down-regulated in HCC. The present study, therefore, aimed to investigate whether expression levels for the full spectrum of let-7 family members (let-7a, 7b, 7c, 7d, 7e, 7f, 7g, 7i, and miR-98) in the circulatory system are useful as surveillance biomarkers for liver-related diseases to monitor treatment efficacy during HCV infection. To this end, we measured the levels of mature circulating let-7 family members using quantitative reverse transcription-PCR in 236 patients with HCV infection, and 147 age- and sex-matched controls. Using hierarchical cluster analysis and principal component analysis, three clusters were obtained after measuring expression levels of let-7 family members in the patients and controls. Cluster 1 included let-7a/d/e/g, Cluster 2 comprised let-7b and let-7i, and Cluster 3 comprised let-7c/f/miR-98. Let-7b/c/g represented the three clusters and showed the best survival response to liver cancer when analyzed with respect to patient data. Therefore, considering the circulating levels of let7 b/c/g as representatives of the let-7 family may facilitate effective monitoring of liver-related disease.

[1]  Mary Goldman,et al.  The UCSC Xena platform for public and private cancer genomics data visualization and interpretation , 2018, bioRxiv.

[2]  Xiaowei Wang,et al.  OncomiR: an online resource for exploring pan-cancer microRNA dysregulation , 2018, Bioinform..

[3]  G. Dore,et al.  Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression. , 2017, Journal of hepatology.

[4]  Y. Hoshida,et al.  Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals , 2017, BMC Medicine.

[5]  Chien-Jen Chen,et al.  Risk of hepatitis C virus related hepatocellular carcinoma between subjects with spontaneous and treatment-induced viral clearance , 2017, Oncotarget.

[6]  K. Matsuura,et al.  Circulating let‐7 levels in plasma and extracellular vesicles correlate with hepatic fibrosis progression in chronic hepatitis C , 2016, Hepatology.

[7]  S. Lheureux,et al.  Towards a new standardized method for circulating miRNAs profiling in clinical studies: Interest of the exogenous normalization to improve miRNA signature accuracy , 2016, Molecular oncology.

[8]  S. Juo,et al.  MicroRNA let-7g cooperates with interferon/ribavirin to repress hepatitis C virus replication , 2016, Journal of Molecular Medicine.

[9]  R. Thimme,et al.  Suppressive effect of interleukin 10 on priming of naive hepatitis C virus-specific CD8+ T cells. , 2015, The Journal of infectious diseases.

[10]  T. Luedde,et al.  Circulating microRNAs as markers of liver inflammation, fibrosis and cancer. , 2014, Journal of hepatology.

[11]  N. Bardeesy,et al.  Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma. , 2014, Journal of hepatology.

[12]  M. Yeh,et al.  Baseline gamma-glutamyl transferase levels strongly correlate with hepatocellular carcinoma development in non-cirrhotic patients with successful hepatitis C virus eradication. , 2014, Journal of hepatology.

[13]  A. Sanyal,et al.  Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis , 2014, Gut.

[14]  S. Juo,et al.  Peripheral blood mononuclear cells microRNA predicts treatment outcome of hepatitis C virus genotype 1 infection. , 2014, Antiviral research.

[15]  Q. Jin,et al.  High-Throughput Profiling of Alpha Interferon- and Interleukin-28B-Regulated MicroRNAs and Identification of let-7s with Anti-Hepatitis C Virus Activity by Targeting IGF2BP1 , 2013, Journal of Virology.

[16]  G. Reid,et al.  The Impact of Hemolysis on Cell-Free microRNA Biomarkers , 2013, Front. Genet..

[17]  G. Teng,et al.  Let-7b Is Involved in the Inflammation and Immune Responses Associated with Helicobacter pylori Infection by Targeting Toll-Like Receptor 4 , 2013, PloS one.

[18]  Chien-Jen Chen,et al.  Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study. , 2012, The Journal of infectious diseases.

[19]  D. Cooper,et al.  Differential Regulation of the Let-7 Family of MicroRNAs in CD4+ T Cells Alters IL-10 Expression , 2012, The Journal of Immunology.

[20]  P. Jansen,et al.  Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma. , 2012, Journal of hepatology.

[21]  S. Morini,et al.  Toll-like receptor-4 expression by hepatic progenitor cells and biliary epithelial cells in HCV-related chronic liver disease , 2012, Modern Pathology.

[22]  Hsien-Da Huang,et al.  Let-7b is a novel regulator of hepatitis C virus replication , 2012, Cellular and Molecular Life Sciences.

[23]  J. Clements,et al.  Relationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patients , 2012, Retrovirology.

[24]  R. Gregory,et al.  Molecular Basis for Interaction of let-7 MicroRNAs with Lin28 , 2011, Cell.

[25]  C. Sarrazin,et al.  Multi-center evaluation of the Abbott RealTime HCV assay for monitoring patients undergoing antiviral therapy for chronic hepatitis C. , 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[26]  R. May,et al.  Hepatitis C Virus-Induced Cancer Stem Cell-Like Signatures in Cell Culture and Murine Tumor Xenografts , 2011, Journal of Virology.

[27]  Nicola J. Armstrong,et al.  Haemolysis during Sample Preparation Alters microRNA Content of Plasma , 2011, PloS one.

[28]  A. Kazlauskas Faculty Opinions recommendation of An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. , 2010 .

[29]  R. Porte,et al.  The role of platelets in liver inflammation and regeneration. , 2010, Seminars in thrombosis and hemostasis.

[30]  Sun-Mi Park,et al.  The role of let-7 in cell differentiation and cancer. , 2010, Endocrine-related cancer.

[31]  Y. Shiloh,et al.  Accelerated carcinogenesis following liver regeneration is associated with chronic inflammation-induced double-strand DNA breaks , 2010, Proceedings of the National Academy of Sciences.

[32]  Kevin Struhl,et al.  An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation , 2009, Cell.

[33]  X. Chen,et al.  Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases , 2008, Cell Research.

[34]  F. Slack,et al.  The let-7 family of microRNAs. , 2008, Trends in cell biology.

[35]  Daniel B. Martin,et al.  Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.

[36]  Sheng-Nan Lu,et al.  A Sustained Virological Response to Interferon or Interferon/Ribavirin Reduces Hepatocellular Carcinoma and Improves Survival in Chronic Hepatitis C: A Nationwide, Multicentre Study in Taiwan , 2006, Antiviral therapy.

[37]  G. Petsko Transformation , 2006, Genome Biology.

[38]  M. Lai,et al.  Hepatitis C Virus Induces Toll-Like Receptor 4 Expression, Leading to Enhanced Production of Beta Interferon and Interleukin-6 , 2006, Journal of Virology.

[39]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[40]  C. Croce,et al.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Yoshiharu Matsuura,et al.  The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice , 1998, Nature Medicine.